116 related articles for article (PubMed ID: 2552627)
1. Neopterin excretion after liver transplantation and its value in differential diagnosis of complications.
Tilg H; Vogel W; Aulitzky WE; Schönitzer D; Margreiter R; Dietze O; Judmaier G; Wachter H; Huber C
Transplantation; 1989 Oct; 48(4):594-9. PubMed ID: 2552627
[TBL] [Abstract][Full Text] [Related]
2. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
3. Urinary and pancreatic juice neopterin excretion after combined pancreas-kidney transplantation.
Tilg H; Königsrainer A; Krausler R; Aulitzky WE; Margreiter R; Reibnegger G; Wachter H; Huber C
Transplantation; 1992 Apr; 53(4):804-8. PubMed ID: 1314440
[TBL] [Abstract][Full Text] [Related]
4. Biliary and urinary neopterin concentrations in monitoring liver-allograft recipients.
Hausen A; Aichberger C; Königsrainer A; Weiss G; Margreiter R; Wachter H
Clin Chem; 1993 Jan; 39(1):45-7. PubMed ID: 8380366
[TBL] [Abstract][Full Text] [Related]
5. Neopterin and interferon gamma serum levels in renal allograft recipients.
Khoss AE; Balzar E; Steger H; Howanietz H; Wladika W; Hamilton G; Woloszczuk W
Child Nephrol Urol; 1988-1989; 9(1-2):46-9. PubMed ID: 3150820
[TBL] [Abstract][Full Text] [Related]
6. Neopterin as a new marker to detect acute rejection after heart transplantation.
Havel M; Laczkovics A; Teufelsbauer H; Müller MM; Wolner E
J Heart Transplant; 1989; 8(2):167-70. PubMed ID: 2651621
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of serum beta 2 microglobulin and neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Bäckman L; Ringdén O; Björkhem I
Transplant Proc; 1988 Jun; 20(3):410-2. PubMed ID: 2837852
[No Abstract] [Full Text] [Related]
8. Different cellular patterns associated with hepatitis C virus reactivation, cytomegalovirus infection, and acute rejection in liver transplant patients monitored with transplant aspiration cytology.
Lautenschlager I; Nashan B; Schlitt HJ; Hoshino K; Ringe B; Tillmann HL; Manns M; Wonigeit K; Pichlmayr R
Transplantation; 1994 Dec; 58(12):1339-45. PubMed ID: 7809926
[TBL] [Abstract][Full Text] [Related]
9. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation.
Härmä M; Loginov R; Piiparinen H; Halme L; Höckerstedt K; Lautenschlager I
Transplant Proc; 2005 Mar; 37(2):1230-2. PubMed ID: 15848678
[TBL] [Abstract][Full Text] [Related]
10. [Differential diagnosis of transplant function disorders in therapy with monoclonal antibodies OKT3].
Müller T; Keuchel M; Schindler S; Steinmetz A; Feiber H; Lange H
Helv Chir Acta; 1991 Sep; 58(3):271-5. PubMed ID: 1769844
[TBL] [Abstract][Full Text] [Related]
11. Neopterin--its clinical use in urinalysis.
Fuchs D; Stahl-Hennig C; Gruber A; Murr C; Hunsmann G; Wachter H
Kidney Int Suppl; 1994 Nov; 47():S8-11. PubMed ID: 7869677
[TBL] [Abstract][Full Text] [Related]
12. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
13. Neopterin levels in long-term renal allograft recipients.
König P; Margreiter R; Huber C; Fuchs D; Hausen A; Reibnegger G; Wachter H
Immunobiology; 1985 Mar; 169(2):208-12. PubMed ID: 3888825
[TBL] [Abstract][Full Text] [Related]
14. Immune activation and enhanced urinary zinc concentrations in allograft recipients.
Melichar B; Aichberger C; Artner-Dworzak E; Weiss G; Margreiter R; Wachter H; Fuchs D
Presse Med; 1994 Apr; 23(15):702-6. PubMed ID: 8072975
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation.
Peterson PK; Balfour HH; Marker SC; Fryd DS; Howard RJ; Simmons RL
Medicine (Baltimore); 1980 Jul; 59(4):283-300. PubMed ID: 6248718
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant neopterin excretion in renal allograft recipients--a reliable diagnostic aid for acute rejection and a predictive marker of long-term graft survival.
Reibnegger G; Aichberger C; Fuchs D; Hausen A; Spielberger M; Werner ER; Margreiter R; Wachtehr H
Transplantation; 1991 Jul; 52(1):58-63. PubMed ID: 1858155
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of heart allograft rejection by simultaneous measurement of serum beta 2-microglobulin and urinary neopterin.
Schmitt F; Myara I; Benoit MO; Guillemain R; Amrein C; Dreyfus G; Paris M; Moatti N
Ann Biol Clin (Paris); 1989; 47(5):237-41. PubMed ID: 2662838
[TBL] [Abstract][Full Text] [Related]
18. Serum neopterin/creatinine values correlate with severity of symptoms caused by cytomegalovirus infection in renal transplant recipients.
Raasveld MH; Bloemena E; Wertheim-van Dillen P; Surachno J; Wilmink JM; ten Berge IJ
Transpl Int; 1993 Jan; 6(1):42-4. PubMed ID: 8383975
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with cytomegalovirus-positive antigenemia in orthotopic liver transplant patients.
Hoppe L; Bressane R; Lago LS; Schiavo FL; Marroni CA; Keiserman DR; Brandão AB; Júnior AM; Cassal AP; Zanotelli ML; Cantisani GP
Transplant Proc; 2004 May; 36(4):961-3. PubMed ID: 15194334
[TBL] [Abstract][Full Text] [Related]
20. Functional hyperactivity of monocytes after bone marrow transplantation: possible relevance for the development of post-transplant complications or relapse.
Castenskiold EC; Kelsey SM; Collins PW; Coldwell RD; Allen PD; Side LE; Makin HL; Goldstone AH; Newland AC
Bone Marrow Transplant; 1995 Jun; 15(6):879-84. PubMed ID: 7581085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
